Literature DB >> 14769029

Structural basis of the unusual stability and substrate specificity of ervatamin C, a plant cysteine protease from Ervatamia coronaria.

Piyali Guha Thakurta1, Sampa Biswas, Chandana Chakrabarti, Monica Sundd, Medicherla V Jagannadham, Jiban K Dattagupta.   

Abstract

Ervatamin C is an unusually stable cysteine protease from the medicinal plant Ervatamia coronaria belonging to the papain family. Though it cleaves denatured natural proteins with high specific activity, its activity toward some small synthetic substrates is found to be insignificant. The three-dimensional structure and amino acid sequence of the protein have been determined from X-ray diffraction data at 1.9 A (R = 17.7% and R(free) = 19.0%). The overall structure of ervatamin C is similar to those of other homologous cysteine proteases of the family, folding into two distinct left and right domains separated by an active site cleft. However, substitution of a few amino acid residues, which are conserved in the other members of the family, has been observed in both the domains and also at the region of the interdomain cleft. Consequently, the number of intra- and interdomain hydrogen-bonding interactions is enhanced in the structure of ervatamin C. Moreover, a unique disulfide bond has been identified in the right domain of the structure, in addition to the three conserved disulfide bridges present in the papain family. All these factors contribute to an increase in the stability of ervatamin C. In this enzyme, the nature of the S2 subsite, which is the primary determinant of specificity of these proteases, is similar to that of papain, but at the S3 subsite, Ala67 replaces an aromatic residue, and has the effect of eliminating sufficient hydrophobic interactions required for S3-P3 stabilization. This provides the possible explanation for the lower activity of ervatamin C toward the small substrate/inhibitor. This substitution, however, does not affect the binding of denatured natural protein substrates to the enzyme significantly, as there exist a number of additional interactions at the enzyme-substrate interface outside the active site cleft.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769029     DOI: 10.1021/bi0357659

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Crystallization and preliminary X-ray diffraction studies of the cysteine protease ervatamin A from Ervatamia coronaria.

Authors:  Sibani Chakraborty; Sampa Biswas; Chandana Chakrabarti; Jiban K Dattagupta
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-06-01

2.  The origin and functional transition of P34.

Authors:  Q-G Li; Y-M Zhang
Journal:  Heredity (Edinb)       Date:  2012-12-05       Impact factor: 3.821

3.  Structural insight of dopamine β-hydroxylase, a drug target for complex traits, and functional significance of exonic single nucleotide polymorphisms.

Authors:  Abhijeet Kapoor; Manish Shandilya; Suman Kundu
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

4.  Survey of the rubber tree genome reveals a high number of cysteine protease-encoding genes homologous to Arabidopsis SAG12.

Authors:  Zhi Zou; Jianting Liu; Lifu Yang; Guishui Xie
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

5.  Virtual screening and molecular dynamics simulation study of plant protease inhibitors against SARS-CoV-2 envelope protein.

Authors:  Manisha Kirar; Hitesh Singh; Neelam Sehrawat
Journal:  Inform Med Unlocked       Date:  2022-03-14

6.  Enhancement of proteolytic activity of a thermostable papain-like protease by structure-based rational design.

Authors:  Sruti Dutta; Jiban Kanti Dattagupta; Sampa Biswas
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

7.  Developing novel anthelmintics from plant cysteine proteinases.

Authors:  Jerzy M Behnke; David J Buttle; Gillian Stepek; Ann Lowe; Ian R Duce
Journal:  Parasit Vectors       Date:  2008-09-01       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.